BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Retina
,
Human chorionic gonadotropin
,
Trichostatin A
,
rs2230926
,
MDM2
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tabex
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
An uncontrolled trial of cytisine (Tabex) for smoking cessation.
Variations in binding among several agonists at two stoichiometries of the neuronal, α4β2 nicotinic …
Nicotine receptor partial agonists for smoking cessation.
Nicotine receptor partial agonists for smoking cessation.
Nicotine receptor partial agonists for smoking cessation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Cytisine Pharmacokinetics and Dose Response (C-DRAKS 3 and C-DRAKS 4)
Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)
Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and …
IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL
A Randomized, Controlled, Double-masked, Investigator-initiated Trial to Evaluate Tear Film Quality …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ